CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 63  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0791
LYS 10.0397
GLU 20.0369
LEU 30.0415
ARG 40.0091
CYS 50.0183
GLN 60.0113
CYS 70.0060
ILE 80.0152
LYS 90.0249
THR 100.0188
TYR 110.0142
SER 120.0194
LYS 130.0211
PRO 140.0124
PHE 150.0086
HIS 160.0254
PRO 170.0110
LYS 180.0240
PHE 190.0233
ILE 200.0125
LYS 210.0298
GLU 220.0121
LEU 230.0154
ARG 240.0127
VAL 250.0159
ILE 260.0162
GLU 270.0252
SER 280.0332
GLY 290.0654
PRO 300.0791
HIS 310.0398
CYS 320.0234
ALA 330.0249
ASN 340.0264
THR 350.0064
GLU 360.0122
ILE 370.0112
ILE 380.0113
VAL 390.0093
LYS 400.0238
LEU 410.0194
SER 420.0246
ASP 430.0139
GLY 440.0230
ARG 450.0126
GLU 460.0229
LEU 470.0145
CYS 480.0093
LEU 490.0115
ASP 500.0191
PRO 510.0089
LYS 520.0669
GLU 530.0117
ASN 540.0288
TRP 550.0246
VAL 560.0191
GLN 570.0146
ARG 580.0158
VAL 590.0238
VAL 600.0288
GLU 610.0204
LYS 620.0230
PHE 630.0179
LEU 640.0215
LYS 650.0156
ARG 660.0144
ALA 670.0206
GLU 680.0221
ASN 690.0526

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.